CAR-T Cell Therapy Market Size, Share & Growth Analysis By Product Type (Axicabtagene Ciloleucel, Tisagenlecleucel, Brexucabtagene Autoleucel, Lisocabtagene Maraleucel, Idecabtagene Vicleucel, and Others) By Indication (Acute Lymphocytic Leukemia, Diffuse Large B-Cell Lymphoma, Mantle Cell Lymphoma, Follicular Lymphoma, Multiple Myeloma, and Others) By End-user (Hospitals and Cancer Treatment Centers), And Regional Forecast, 2025-2035

  • Category:Pharmaceuticals & Healthcare
  • Published on:Feb 2025
  • Pages:160
  • Formats:
  • Report Code:41042

Report Summary

The Global CAR-T Cell Therapy Market Size, Share & Growth Analysis By Product Type (Axicabtagene Ciloleucel, Tisagenlecleucel, Brexucabtagene Autoleucel, Lisocabtagene Maraleucel, Idecabtagene Vicleucel, and Others) By Indication (Acute Lymphocytic Leukemia, Diffuse Large B-Cell Lymphoma, Mantle Cell Lymphoma, Follicular Lymphoma, Multiple Myeloma, and Others) By End-user (Hospitals and Cancer Treatment Centers), And Regional Forecast, 2025-2035, This research & consulting report doles out information about the global CAR-T Cell Therapy market. The forecast period of the market extends till 2035, while commencing in 2024. The report sheds light on various key insights & trends that have occupied center stage & drawn end-users' attention. The CAR-T Cell Therapy industry is witnessing impressive expansion at present, having logged double-digit CAGRs in the past.

The Global CAR-T Cell therapy market is projected to mature from a revenue of USD 4.13 Billion in 2024 and reach USD 22.1 Billion by 2035.

The report alludes to the CAR-T Cell Therapy market as a lucrative sector. This sector is slated to generate substantial revenues during forecast period 2025 to 2035. The analytical report highlights data & overview regarding the size, shares, & demand of CAR-T Cell Therapy. Several other factors have had a positive or negative impact on the industry, all of which have been laid out in details.

Pros & Scope of The Report

The said factors comprise drivers, novel prospects, hindrances, and other vital characteristics of the market. Investments by rivals into CAR-T Cell Therapy products have catapulted the market into limelight & have stoked its demand, globally.

Few among other key aspects that find a mention; encompass the industry segments, predictions, & size and shares for 2025 to 2035. Besides these; the report narrows down on the innovative trends & technological developments, expansion strategies of key players, and regional statistics.

Some Of The Companies In the CAR-T Cell Therapy Market Are:

  • Bluebird Bio
  • Celgene Corporation
  • Gilead Sciences, Inc.
  • Cellectis
  • Servier Laboratories
  • Pfizer Inc.
  • Mereck KGaA
  • Amgen Inc.
  • Intellia Therapeutics
  • Novartis International AG
  • Caribou Biosciences, Inc.
  • Celyad
  • Bellicum Pharmaceuticals, Inc.
  • Noile-Immune Biotech
  • Nanjing Legend Biotechnology Co., Ltd.
  • Johnson & Johnson
  • Sangamo Therapeutics, Inc.

More Inputs & Objectives

The manner in which nascent & local competitors stack up against prominent players, hogs the spotlight. Novel products & services, coupled with the monetary shares of eminent competitors and the SWOT analysis unveil the complexities of the global industry size.

Segments Covered in the Report

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends from 2025 to 2035 in each of the sub segments. For the purpose of this study, Eternity Insights has segmented the global CAR-T Cell Therapy market on the basis of product type, indication, end-user and region:

CAR-T Cell Therapy Market, Product Type

  • Axicabtagene Ciloleucel
  • Tisagenlecleucel
  • Brexucabtagene Autoleucel
  • Lisocabtagene Maraleucel
  • Idecabtagene Vicleucel
  • Others

CAR-T Cell Therapy Market, By Indication

  • Acute Lymphocytic Leukemia
  • Diffuse Large B-cell lymphoma
  • Mantle Cell Lymphoma
  • Follicular Lymphoma
  • Multiple Myeloma
  • Others

CAR-T Cell Therapy Market, By Target Antigen

  • CD19/CD22
  • BCMA (B-Cell Maturation Antigen)
  • Others (MUC16, L1CAM, ROR1, EGFRvIII, PSCA, NKR-2, IL13Ra2, LewisY)

CAR-T Cell Therapy Market, By End-user

  • Hospitals
  • Cancer Treatment Centers

CAR-T Cell Therapy Market, By Regional Outlook

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Switzerland
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • India
    • Rest of APAC
  • Latin America
    • Brazil
    • Rest of LATAM
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • South Africa
    • Turkey
    • Rest of MEA

Research Methodology

Research methodology is an integral component of any kind of high-level market research. It entails evaluation by expert panels, research on secondary & primary levels, checks on quality, & testing on completion. Secondary research deeply focuses on the whys, whos, wheres, whens, & hows and caters to answering the strictly consumer-centric base of people.

Some other secondary research sources comprise governmental affiliations & blogs, business magazines, and industrial journals. Primary research includes face-to-face & telephonic interviews with industry experts. It is comparatively more detailed & lays stress on unprejudiced opinions about the products & services.

Primary research findings cement secondary research & help end-users & businesses get a better hang of various markets. It is a well-established fact, though, that research methodology is best implemented through the mixed execution of its aforementioned procedures.

What Does the Report Offer?

  • A break down & profiling of the qualitative & quantitative analysis of the industry.
  • An in-depth overview of the segments & sub-segments of the industry, unlocking their shares and positions.
  • Data on market players & their growth strategies.
  • Industry outlook, via value chains.
  • Mergers & acquisitions, the SWOT analysis of prominent competitors, and high-tech product launches.
  • Drivers, hindrances, factors that positively & negatively impact the market, and new opportunities.
  • Crucial information and actionable insights, enabling businesses to widen their traction & to have an edge over others.
  • Regions into which the global market is fragmented and the reigning regional markets & their respective shares & revenues.
  • Analytical support on the purchases made/orders passed.

Other Vital Points That Are Covered

  • The impact of Covid-19 on each of the segments of the CAR-T Cell Therapy market.
  • The suppliers, manufacturers, raw materials, dominating players, etc.
  • Key regional contributors & their shares in the past and the future.
  • Evaluation of most of the important countries within particular regions in view of their revenues, supplies, supremacy, business returns, & consumption volumes.
  • Advanced technologies that surround the market and comprehensive outlook on industry applications, products, end-users, & regions.
  • Technological & statistical data to cater to the demands of businesses, shareholders, & companies and to help them grow further.
  • Comparison of competitors against other players and the dominant companies during the forecast period. Strategies employed by reigning stakeholders to gain further traction & to generate higher revenues.
  • End users that are ahead in the rat race and the positive factors that influence those end users.
  • Applications that should come out on top by the end of the forecast period.
  • Products that occupy the maximum shares and the drivers behind those products.
  • Factors that bode well for the CAR-T Cell Therapy market and a mention of other industries that are closely associated with the CAR-T Cell Therapy market.
  • Regions that open the floodgates to higher investments and greater opportunities.
  • Records of the market sales, volumes, CAGRs, & shares.
  • The market report also brings to light major opportunities and untapped geographies. It is more like a blend of customized research documents & conventional reports. Besides informing buyers about the pros & cons of direct and indirect sales channels, the analysis exhibits illustrations & graphical representations of industry growth and the innovative trends within the industry.

    Table Of Contents

    Choose License Type

    close

    categories